BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4338767)

  • 1. Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis.
    Zbar B; Bernstein ID; Bartlett GL; Hanna MG; Rapp HJ
    J Natl Cancer Inst; 1972 Jul; 49(1):119-30. PubMed ID: 4338767
    [No Abstract]   [Full Text] [Related]  

  • 2. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis.
    Hanna MG; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1972 May; 48(5):1441-55. PubMed ID: 4337912
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultrastructural studies of histiocyte-tumor cell interactions during tumor regression after intralesional injection of Mycobacterium bovis.
    Snodgrass MJ; Hanna MG
    Cancer Res; 1973 Apr; 33(4):701-16. PubMed ID: 4348772
    [No Abstract]   [Full Text] [Related]  

  • 4. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis.
    Zbar B; Tanaka T
    Science; 1971 Apr; 172(3980):271-3. PubMed ID: 4323415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract]   [Full Text] [Related]  

  • 7. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis., 2. Comparative effects of vaccinia virus, oxazolone, and turpentine.
    Hanna MG; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1972 Jun; 48(6):1697-707. PubMed ID: 4341404
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of cryosurgical treatment of experimental intradermal tumors to eradicate microscopic lymph node metastases in guinea pigs.
    Javadpour N; Bagley DH; Zbar B
    J Natl Cancer Inst; 1979 Jun; 62(6):1479-81. PubMed ID: 286120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of bilateral lymph node metastases in guinea pigs by intralesional or paralesional injection of Mycobacterium bovis (BCG).
    Zbar B; Hunter JT; Rapp HJ; Canti GF
    J Natl Cancer Inst; 1978 May; 60(5):1163-8. PubMed ID: 642033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.
    Yarkoni E; Ashley MP; Zbar B; Sugimoto T; Rapp HJ
    Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.
    Zbar B; Ribi E; Meyer T; Azuma I; Rapp HJ
    J Natl Cancer Inst; 1974 May; 52(5):1571-7. PubMed ID: 4364736
    [No Abstract]   [Full Text] [Related]  

  • 12. Eradication of microscopic lymph nodes metastases after injection of living BCG adjacent to the primary tumor.
    Smith HG; Bast RC; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1975 Dec; 55(6):1345-52. PubMed ID: 1107574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets.
    Zbar B; Rapp HJ; Ribi EE
    J Natl Cancer Inst; 1972 Mar; 48(3):831-5. PubMed ID: 4333775
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of Mycobacterium bovis BCG-Praha on the growth of Daels' guinea-pig sarcoma (author's transl)].
    Schwartz E
    Zentralbl Bakteriol Orig A; 1974 Jun; 226(4):497-509. PubMed ID: 4152732
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycobacterial cell wall components in tumor suppression and regression.
    Ribi EE; Meyer TJ; Azuma I; Zbar B
    Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311
    [No Abstract]   [Full Text] [Related]  

  • 16. BCG and cancer (first of two parts).
    Bast RC; Zbar B; Borsos T; Rapp HJ
    N Engl J Med; 1974 Jun; 290(25):1413-20. PubMed ID: 4364286
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery.
    Ashley MP; Zbar B; Hunter JT; Rapp HJ; Sugimoto T
    Cancer Res; 1980 Nov; 40(11):4197-203. PubMed ID: 7471060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor immunity produced by the intradermal inoculation of living tumor cells and living Mycobacterium bovis (strain BCG).
    Zbar B; Bernstein I; Tanaka T; Rapp HJ
    Science; 1970 Dec; 170(3963):1217-8. PubMed ID: 4920656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression by active specific immunotherapy of established dermal tumor transplants and lymph node metastases in guinea pigs.
    Yarkoni E; Rapp HJ
    Infect Immun; 1981 Jan; 31(1):514-6. PubMed ID: 7216457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.